Clinical and histological features and therapeutic strategies for IgA nephropathy Takahito Moriyama Invited review article 09 April 2019 Pages: 1089 - 1099
Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients Chunyu ZhouChangbin LiAi Peng Original article 18 June 2019 Pages: 1100 - 1108
Increased heart rate is associated with intrarenal renin–angiotensin system activation in chronic kidney disease patients Naro OhashiShinsuke IsobeHideo Yasuda Original article 27 May 2019 Pages: 1109 - 1118
Clinical characteristics of HNF1B-related disorders in a Japanese population China NaganoNaoya MorisadaKazumoto Iijima Original article 27 May 2019 Pages: 1119 - 1129
Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease Ismail KocyigitFahir OzturkJonas Axelsson Original article 27 May 2019 Pages: 1130 - 1140
Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma Mari AoeTakafumi KanemitsuNaobumi Mise Original article 10 June 2019 Pages: 1141 - 1146
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis Diego MoriconiDomenico GianneseMaria Francesca Egidi Original article 22 June 2019 Pages: 1147 - 1153
Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome Tomomi KondohYohei IkezumiTetsushi Yoshikawa Original article 11 June 2019 Pages: 1154 - 1160
Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function Kentaro NakaiKoji MitsuikiTakanari Kitazono Original article 18 June 2019 Pages: 1161 - 1168
The cortical rim sign in graft renal infarction Koji MuroTakashi KobayashiMotoko Yanagita Images in Nephrology 18 June 2019 Pages: 1169 - 1170
Impact of acute kidney injury at the onset of idiopathic nephrotic syndrome in Japanese children Shuichiro FujinagaKanako Kusaba Letter to the editor 04 May 2019 Pages: 1171 - 1172
Correction to: Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients Kazuhiko TsuruyaRyutaro ShimazakiEvocalcet Study Group Correction 05 July 2019 Pages: 1173 - 1173